Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients
BackgroundHepatitis C virus (HCV) infects more than 71 million people worldwide and chronic HCV infection increases the risk of liver cirrhosis and failure. Haemodialysis (HD) is one of the renal replacement therapies with risk of HCV transmission. Anti-HCV antibodies are the serological screening t...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Published: |
BioMed Central
2020
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/31691/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|